The effects of different treatments for metabolic acidosis in non-dialytic chronic kidney disease: A systematic review and meta-analysis
DOI:
https://doi.org/10.12957/demetra.2022.63273Keywords:
Chronic Kidney Disease. Renal insufficiency. Metabolic Acidosis. Glomerular Filtration Rate. Alkalis. Diet. Bicarbonate.Abstract
Objective: The objective of this review was to evaluate which treatments are used to treat metabolic acidosis in Chronic Kidney Disease (CKD) and their effects on disease progression. Methods: A systematic review was carried out, using the PRISMA protocol, of randomized clinical studies in the following databases: Science Direct, Cochrane Library, and National Library of Medicine-PubMed. The inclusion criteria were original articles from randomized clinical trials with dietary intervention with an alkaline fruit and vegetable diet, oral alkali supplementation, or any combination used to treat metabolic acidosis in patients with non-dialysis-dependent CKD. Results: A total of seven studies were included in this review. All studies used some oral alkali as treatment, with sodium bicarbonate being the main alkali administered, and 57% (n=4) used an alkaline diet that was either in line or not with oral alkali. All interventions improved the metabolic acidosis condition. As for the Glomerular Filtration Rate (GFR), a delay in the decline of GFR was found in 57% (n=4) of the studies after improvement in metabolic acidosis. Conclusions: The treatment of metabolic acidosis, when added to dietary interventions, obtained more favorable results on the progression of CKD by improving, in addition to serum bicarbonate, other parameters of interest, such as blood pressure, plasma urea, calcium, phosphatemia, urinary sodium, urinary potassium, urinary albumin, and LDL. Thus, the data support the use of an alkaline diet in treatments to treat metabolic acidosis in patients with CKD.
Downloads
References
Brasil, Ministério da Saúde. Diretrizes clínicas para o cuidado ao paciente com Doença Renal Crônica – DRC no Sistema Único de Saúde. Secretaria de Atenção à Saúde, 2014.
Crewes DC, Bello AK, Saadi G. 2019 World Kidney Day Editorial - burden, access, and disparities in kidney disease. "Kidney International, volume 95, páginas 242- 248, Copyright World Kidney Day 2019. Comitê Diretor (2019).
Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl., v. 3, issue 1, 2013.
Laboux T, Azar R. Contrôle diététique de l’acidose métabolique chez le patient insuffisant rénal chronique. Nephrol. Ther. 2019; 15(7): 491-497.
Chen W, Abramowitz MK. Metabolic acidosis and the progression of chronic kidney disease. BMC Nephrol. 2014;15(1): 1-8.
Siener R. Dietary Treatment of Metabolic Acidosis in Chronic Kidney Disease. Nutrients. 2018;10(4):512.
Scialla JJ, Anderson CA. Dietary acid load: a novel nutritional target in chronic kidney disease?. Adv Chronic Kidney Dis. 2013;20(2):141-149.
Galvão TF, Pansani TDSA, Harrad D. Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiol. Serv. Saúde 2015; 24(2):335-342.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17(1):1-12.
Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3): 371-381.
Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int, 2014;86(5): 1031-1038.
Jeong J, Kwon SK, Kim HY: Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease. Electrolyte Blood Press. 2014;12: 80–87.
Di Iorio BR, Di Micco L, Marzocco S, De Simone E, De Blasio, A, Sirico ML. Very low-protein diet (VLPD) reduces metabolic acidosis in subjects with chronic kidney disease: the “nutritional light signal” of the renal acid load. Nutrients. 2017; 9(1), 69.
Bushinsky DA, Hostetter T, Klaerner G, Stasiv Y, Lockey C, McNulty S, Buysse J. Randomized, controlled trial of TRC101 to increase serum bicarbonate in patients with CKD. Clin J Am Soc Nephrol. 2018;13(1): 26-35.
Wesson D E, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, Bushinsky DA. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial. Lancet. 2019a; 393(10179):1417-1427.
Wesson DE, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, Bushinsky DA. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: A multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet. 2019b; 394(10196): 396-406.
Navaneethan SD, Shao J, Buysse J, Bushinsky DA. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol, 2019;14(7): 1011-1020.
Angéloco LRN, de Souza GCA, Romao EA, Chiarello PG. Alkaline diet and metabolic acidosis: practical approaches to the nutritional management of chronic kidney disease. J Ren Nutr. 2018; 28(3): 215-220.
Oliveira CMCD, Vidal CLDC, Cristino EF, Pinheiro Jr FML, Kubrusly M. Acidose metabólica e sua associação com o estado nutricional em hemodiálise. Braz. J. Nephrol.2015; 37(4): 458-466.
Downloads
Published
How to Cite
Issue
Section
License
STATEMENT OF AUTHORSHIP RESPONSIBILITY
Title of the manuscript:
________________________________________________________
1. Statement of responsability
I certify that I have participated in the work above specified and take public responsibility for its content.
I certify that the manuscript represents an original work and that none of the material in the manuscript has been previously published, is included in another manuscript, or is currently under consideration for publication elsewhere, whether in printed form or in electronic media, except that described in the attachment.
In case of acceptance of this text by Demetra: Alimentação, Nutrição & Saude, I declare to be in accordance with the policy of public access and copyright adopted by Demetra, which provides as follows: (a) the authors retain the copyright and grant to the Journal the right of first publication, the work being simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of the work with acknowledgment of authorship and initial publication in this journal; (b) authors are authorized to enter additional contracts separately for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or book chapter), with acknowledgment of authorship and initial publication in this journal; and (c) authors are permitted and encouraged to post and distribute their work online (eg, in institutional repositories or on their personal page) at any point before or during the editorial process, as this may lead to productive changes, as well as increase the impact and citation of the published work.
2. Conflict of Interest Statement
I certify that there is no conflict of interest in connection with the submitted article.
Date, signature and full address of all authors.
